Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids: A Bayesian Reanalysis of a Previous Meta-analysis

IMPORTANCE: A World Health Organization (WHO) meta-analysis found that tocilizumab was associated with reduced mortality in hospitalized patients with COVID-19. However, uncertainty remains concerning the magnitude of tocilizumab’s benefits and whether its association with mortality benefit is simil...

Descripción completa

Detalles Bibliográficos
Autores principales: Albuquerque, Arthur M., Tramujas, Lucas, Sewanan, Lorenzo R., Williams, Donald R., Brophy, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886529/
https://www.ncbi.nlm.nih.gov/pubmed/35226077
http://dx.doi.org/10.1001/jamanetworkopen.2022.0548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886529/
https://www.ncbi.nlm.nih.gov/pubmed/35226077
http://dx.doi.org/10.1001/jamanetworkopen.2022.0548

Ejemplares similares